SILVERN applied to the wound site can assist to inhibit the spread of dangerous bacteria while also lowering treatment expenses, which benefits the community. According to in vitro skin cell and in vivo animal testing assays, SILVERN exhibits significant antibacterial activity against diverse bacteria, is safe for humans, and acts as an antibacterial wound healing agent. Copyrights for the biosynthesis process and its use as an antibacterial wound healing agent have been filed (LY2020004347 & LY2021E05078). Silver nanoparticles, antimicrobials, and wound healing have a big market, hence SILVERN’s commercialization potential is enormous. A few local companies have been identified as potential industrial partners for our commercialization approach. SILVERN has the advantage of being able to generate silver nanoparticles in a sustainable manner without generating toxic waste, contributing to the circular economy manufacturing inventiveness.